» Articles » PMID: 24958480

Underuse of 24-hour Urine Collection Among Children with Incident Urinary Stones: a Quality-of-care Concern?

Overview
Journal Urology
Specialty Urology
Date 2014 Jun 25
PMID 24958480
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the prevalence of 24-hour urine collection among first-time pediatric stone formers and investigate factors associated with its use.

Materials And Methods: Using data from the MarketScan Commercial Claims and Encounters Database (2002-2006), children presenting to the emergency department with an incident episode of upper urinary tract stone disease were identified through a diagnosis code-based algorithm. The number of patients performing a 24-hour urine collection within 6 months of this encounter was calculated. Temporal trends in the prevalence of use were assessed. We fitted multivariate logistic regression models to examine factors associated with testing.

Results: In total, 1848 children presented with an incident upper tract stone, of which 12.0% submitted a 24-hour urine collection. This percentage remained stable over the study period. Testing was more common among younger patients (P <.001) and those who visited urologists (P <.001) or nephrologists (P <.001). The odds of testing were nearly 4-fold or 7-fold higher if the patient saw a urologist (odds ratio, 3.99; 95% confidence interval, 2.83-5.62) or a nephrologist (odds ratio, 7.00; 95% confidence interval, 3.95-12.41), respectively.

Conclusion: Despite rates of stone recurrence, 24-hour urine collection appears to be underused among children. Efforts to increase its use are therefore likely to benefit pediatric patients with urinary stone disease.

Citing Articles

Preventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease.

Arivoli K, Valicevic A, Oerline M, Hsi R, Patel S, Hollingsworth J Clin J Am Soc Nephrol. 2024; 19(5):565-572.

PMID: 38345854 PMC: 11108239. DOI: 10.2215/CJN.0000000000000428.


Associations Between Provider Specialty and Use of Follow-up Testing Among Patients on Preventive Pharmacological Therapy for Urinary Stone Disease.

Crivelli J, Yan P, Shahinian V, Hsi R, Hollingsworth J Urol Pract. 2023; 10(4):400-406.

PMID: 37341368 PMC: 10313156. DOI: 10.1097/UPJ.0000000000000414.


How to Monitor Hydration Status and Urine Dilution in Patients with Nephrolithiasis.

Travers S, Prot-Bertoye C, Daudon M, Courbebaisse M, Baron S Nutrients. 2023; 15(7).

PMID: 37049482 PMC: 10097240. DOI: 10.3390/nu15071642.


Specialist Care, Metabolic Testing, and Testing Completeness Among U.S. Veterans with Urinary Stone Disease.

Hsi R, Valicevic A, Patel S, Oerline M, Pao A, Leppert J Urol Pract. 2022; 10(1):49-56.

PMID: 36545539 PMC: 9762689. DOI: 10.1097/upj.0000000000000356.


Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease.

Hsi R, Yan P, Crivelli J, Goldfarb D, Shahinian V, Hollingsworth J Urology. 2022; 166:111-117.

PMID: 35545149 PMC: 9356981. DOI: 10.1016/j.urology.2022.04.031.